VTAK

Catheter Precision Inc. Common Stock (VTAK)

Stock · AMEX · Health Care

$0.84as of 10/16/2026

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

October 3, 2026

Catheter Precision to Rename to Flyte Aviation and Execute Reverse Split. Catheter Precision announced it will change its name to Flyte Aviation and its ticker symbol to VJET, effective Monday, October 5. The company will also implement a 1-for-10 reverse stock split at the market open. Additionally, the new entity has been named the official air travel partner for the 34th Annual Hamptons International Film Festival.

Active signals

Support level
$0.14725
Industry
Medical/Dental Instruments

What VTAK's price did in the 20 trading sessions after each past signal, compared with any 20-session window over the same period.

SignalTimesMedian 20-session returnHigher after 20 sessions
Volume Spike23-25.0%35%
Bollinger Band Breakdown23-1.8%39%
Bollinger Band Breakout18-19.9%11%
Any 20-session window (baseline)-15.3%27%

Computed by MarketWall from daily closing prices since May 18, 2022. Returns are close-to-close and don't include dividends. Past results describe what happened before; they are not a forecast and not investment advice.

About VTAK

Catheter Precision, Inc. designs, manufactures, and sells medical technologies for the field of cardiac electrophysiology (EP) in the United States and Europe. The company's lead product is View into Ventricular Onset System, a non-invasive imaging system that offers 3D cardiac mapping to help with localizing the sites of origin of idiopathic ventricular arrhythmias in patients with structurally normal hearts prior t…

Sector
Health Care
Industry
Medical/Dental Instruments
Employees
17

Fundamentals

1-day range
$0.1476$0.158
Market cap
$977.1K
P/E (trailing)
—
P/E (forward)
-0.04
EPS (trailing)
$-7.07
Dividend yield
—
Beta
-1.17
Avg. volume
726.7K
Dividend pay date
November 17, 2020
52-week range
$0.82$30.6

How Catheter Precision Inc. Common Stock Makes Money

Where the revenue actually goes — FY2025 annual results

market-wall.comTotalRevenue$819.0KSG&A$12.07M (1474%)Cost of Revenue$63.0K (8%)VTAK

Source: 10-K filed Mar 31, 2026 · via SEC EDGAR / Finnhub

Gross Profit$756.0K(92%)
Operating Income-$21.14M(-2582%)

Catheter Precision Inc. Common Stock Competitors

Chosen by industry and closest market cap.

  • VTAK
    Catheter Precision Inc. Common Stock
    $0.84
    ▼ 14.29%
    Market cap $977.1KP/E —
    $0.82$30.6
  • BJDX
    Bluejay Diagnostics Inc. Common Stock
    $0.745
    ▼ 4.36%
    Market cap $1.19MP/E —
    $0.755$16.68
  • BEATW
    Heartbeam Inc. Warrant
    $0.0031
    ▼ 65.56%
    Market cap $1.19MP/E —
    $0.005$0.5601
  • PFSA
    Profusa Inc. Common Stock
    $0.931
    ▼ 12.99%
    Market cap $686.5KP/E —
    $1.25$3,000
  • TNONW
    Tenon Medical Inc. Warrant
    $0.0054
    ▼ 8.47%
    Market cap $85.3KP/E —
    $0.0038$0.043
  • ICUCW
    SeaStar Medical Holding Corporation Warrant
    $0.02
    ▲ 28.21%
    Market cap $79.1KP/E —
    $0.0084$0.0452
  • WOK
    WORK Medical Technology Group LTD Class A Ordinary Shares
    $1.09
    ▼ 18.66%
    Market cap $35.7KP/E —
    $1.25$83,600

P/E shows — for peers not currently carrying a live signal of their own.

See the full, filterable feed with live charts on the MarketWall dashboard.

We use analytics to understand how market-wall is used. No personal data is sold.